KA/EN
Register
Medicines reference
Search
Search
Product

Hipradog 7

Favourites

Canine parvovirus + Canine distemper virus + Canine adenovirus + Canine parainfluenza virus + Leptospira icterohaemorrhagiae + Leptospira canicola · Laboratorios HIPRA, S.A.

1 form: suspension. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
Suspension · Dog Dog 1 ml
Reconstitute fully with the liquid component and inject one 1 ml dose subcutaneously at 8 weeks, again at 12 weeks, then annually. Use within one hour. Vaccinate healthy, unstressed dogs without suspected intestinal parasites. Do not use during pregnancy. Hypersensitivity is very rare and requires immediate symptomatic treatment. Do not mix or co-administer another vaccine or medicine without a case-specific veterinary decision.
 · at 8 and 12 weeks, then annually		 at 8 and 12 weeks, then annually Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ჰიპრადოგი 7
№ 314-11; 246-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Hipradog 7, Suspension

lyophilisate and suspension for injection, 1 ml dose for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.6/10
Good
vetman assessment

Hipradog 7

lyophilisate and suspension for injection, 1 ml dose for dogs
Assessed clinical scopeDog · Full dog label: active immunisation against CDV, CAV-1/2, CPV, canine parainfluenza and leptospirosis caused by the labelled Canicola and Icterohaemorrhagiae serogroups · Subcutaneous
Care settingPreventive canine vaccination with examination, exposure-risk assessment, cold-chain control and emergency treatment available
vetman score 7.6/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · № 314-11; 246-11 · Verified on 21 Oct 2026

A usable broad combination whose core viral components are valuable, but its 12-week endpoint, annual all-component schedule and bivalent leptospirosis breadth make it less aligned with current best-practice programmes.

Regulatory and scientific credibility8.7/10

The exact combination and presentation are registered in Georgia and have a current regulator SPC with transparent composition and schedule; evidence for duration is mainly label and serology based.

Clinical efficacy6.8/10

The viral core components are strongly supported and parainfluenza may reduce disease, but the puppy course ends at 12 weeks unless supplemented, all components are assigned an annual interval, and the bivalent leptospiral component does not cover the broader serogroup range of current four-component vaccines.

Safety and tolerability7.7/10

The expected profile is generally acceptable in healthy dogs, with very rare hypersensitivity; the live-virus combination, pregnancy restriction and need to avoid unassessed co-administration require routine safeguards.

Clinical practicality7.1/10

A fixed 1 ml SC dose and one combined injection are convenient, but reconstitution, use within one hour, cold chain, two puppy visits, annual repetition and guideline-concordant extension beyond 12 weeks add work.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Vaccinate only healthy, unstressed dogs without suspected intestinal parasites.
  • Do not use during pregnancy.
  • The labelled 8- and 12-week course should be extended with a core dose at 16 weeks or later when maternal antibody is relevant.
  • Leptospiral coverage is limited to the Canicola and Icterohaemorrhagiae serogroups; do not infer four-component breadth.
  • Very rare hypersensitivity requires immediate symptomatic treatment and post-vaccination observation.
  • Do not mix or co-administer another vaccine or medicine without a case-specific veterinary decision.
  • Maintain the cold chain, reconstitute fully, use within one hour and follow the annual label schedule while separating core-component decisions.
Assessment sources
  1. EU UPD SPC 20262026
  2. WSAVA vaccination 20242024
  3. AAHA canine vaccination 20222022
  4. ACVIM leptospirosis consensus 20232023
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Canine parvovirus6 log10 TCID50/dose Canine distemper virus4 log10 TCID50/dose Canine adenovirus4 log10 TCID50/dose Canine parainfluenza virus5 log10 TCID50/dose Leptospira icterohaemorrhagiae9 log10 org/dose Leptospira canicola9 log10 org/dose
Formulation Type
Suspension
Administration route
Subcutaneous
Manufacturer
Laboratorios HIPRA, S.A. · Spain
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ჰიპრადოგი 7
№ 314-11; 246-11
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml
Reconstitute fully with the liquid component and inject one 1 ml dose subcutaneously at 8 weeks, again at 12 weeks, then annually. Use within one hour. Vaccinate healthy, unstressed dogs without suspected intestinal parasites. Do not use during pregnancy. Hypersensitivity is very rare and requires immediate symptomatic treatment. Do not mix or co-administer another vaccine or medicine without a case-specific veterinary decision.
 Dog Any weight Subcutaneous at 8 and 12 weeks, then annually
EU UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Hipradog 7 - official product information
EU Union Product Database, 2026

Canine parvovirus: No dose supported by a publicly verifiable source yet

Canine distemper virus: No dose supported by a publicly verifiable source yet

Canine adenovirus: No dose supported by a publicly verifiable source yet

Canine parainfluenza virus: No dose supported by a publicly verifiable source yet

Leptospira icterohaemorrhagiae: No dose supported by a publicly verifiable source yet

Leptospira canicola: No dose supported by a publicly verifiable source yet

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗